Evidence map›Paper›PMID 28740159›Full record

ArticleScientific reports2017

Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells.

Eleonora Cimini, Concetta Castilletti, Alessandra Sacchi, Rita Casetti, Veronica Bordoni, Antonella Romanelli, Federica Turchi, Federico Martini, Nicola Tumino, Emanuele Nicastri and 7 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Offspring affected withEmerging microbes & infections · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Host immune response against DENV and ZIKV infections.Frontiers in cellular and infection microbiology · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

Eleonora CiminiCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Concetta CastillettiVirology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.ORCID 0000-0001-9819-236X
Alessandra SacchiCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Rita CasettiCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Veronica BordoniCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Antonella RomanelliCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Federica TurchiCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Federico MartiniCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Nicola TuminoCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Emanuele NicastriClinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Angela CorpolongoClinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Antonino Di CaroVirology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.ORCID 0000-0001-6027-3009
Gary KobingerDepartment of Microbiology, Immunology and Infectious Diseases, Faculty of Medicine, Université Laval, Quebec, Canada.
Alimuddin ZumlaDivision of Infection and Immunity, University College London, and NIHR Biomedical Research centre, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Maria Rosaria CapobianchiVirology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Giuseppe IppolitoScientific Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
Chiara AgratiCellular Immunology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy. chiara.agrati@inmi.it.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITUCL Biomedical Research Centre · GBUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The definition of the immunological response to Zika (ZIKV) infection in humans represents a key issue to identify protective profile useful for vaccine development and for pathogenesis studies. No data are available on the cellular immune response in the acute phase of human ZIKV infection, and its role in the protection and/or pathogenesis needs to be clarified. We studied and compared the phenotype and functionality of T-cells in patients with acute ZIKV and Dengue viral (DENV) infections. A significant activation of T-cells was observed during both ZIKV and DENV infections. ZIKV infection was characterized by a CD4 T cell differentiation toward effector cells and by a lower frequency of IFN-γ producing CD4 T cells. Moreover, a substantial expansion of CD3

Indexed as

AdultCD4-Positive T-LymphocytesCell DifferentiationDengue VirusFemaleGranzymesHumansImmunity, CellularInterferon-gammaMaleMiddle AgedT-Lymphocyte SubsetsYoung AdultZika VirusZika Virus InfectionGranzymesIFNG protein, humanInterferon-gamma

Identifiers

PMID28740159
PMCPMC5524759
OpenAlexW2739310347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.